Sumitomo Mitsui DS Asset Management Company Ltd Has $3.57 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.3% in the third quarter, Holdings Channel reports. The firm owned 32,354 shares of the medical device company’s stock after purchasing an additional 715 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Cooper Companies were worth $3,570,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of COO. Quantbot Technologies LP bought a new stake in shares of Cooper Companies in the 1st quarter valued at $2,211,000. Whittier Trust Co. raised its position in shares of Cooper Companies by 298.9% during the first quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock worth $1,211,000 after purchasing an additional 8,947 shares during the period. Envestnet Portfolio Solutions Inc. lifted its holdings in shares of Cooper Companies by 43.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock valued at $3,076,000 after purchasing an additional 10,616 shares in the last quarter. Gulf International Bank UK Ltd grew its position in shares of Cooper Companies by 300.0% in the 1st quarter. Gulf International Bank UK Ltd now owns 17,148 shares of the medical device company’s stock valued at $1,739,000 after purchasing an additional 12,861 shares during the period. Finally, Axxcess Wealth Management LLC increased its stake in Cooper Companies by 298.4% during the 1st quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company’s stock worth $833,000 after purchasing an additional 6,150 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on COO shares. Piper Sandler lifted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Robert W. Baird upped their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and boosted their price target for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Wells Fargo & Company increased their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Finally, Morgan Stanley boosted their target price on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average price target of $115.00.

Cooper Companies Trading Up 1.4 %

Shares of Cooper Companies stock opened at $108.26 on Monday. The stock has a market cap of $21.56 billion, a P/E ratio of 63.68, a P/E/G ratio of 2.56 and a beta of 0.98. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38. The business’s 50 day moving average is $104.28 and its 200-day moving average is $96.44.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.84 earnings per share. Equities research analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Cooper Companies news, CFO Brian G. Andrews sold 24,788 shares of the firm’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares of the company’s stock, valued at $700,422.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is owned by company insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.